Zenas BioPharma, Inc. – NASDAQ:ZBIO

Zenas BioPharma stock price today

$15.5
+5.66
+57.52%

Zenas BioPharma key metrics

Market Cap
 401.19M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Zenas BioPharma stock price history

Zenas BioPharma stock forecast

Zenas BioPharma financial statements

Zenas BioPharma alternative data

Zenas BioPharma
Employees

Zenas BioPharma, Inc. (NASDAQ:ZBIO): Employee count
Dec 2024 114

Zenas BioPharma other data

Zenas BioPharma
Insider Trading

Zenas BioPharma, Inc. (NASDAQ:ZBIO): Insider trades (number of shares)
Period Buy Sel
Nov 2024 10000 0
Dec 2024 70000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MOULDER LEON O JR director, officer: Chief Execut..
 Common Stock 45,000 $9.98 $449,100
Purchase
MOULDER LEON O JR director, officer: Chief Execut..
 Common Stock 25,000 $10.76 $269,000
Purchase
MOULDER LEON O JR director, officer: Chief Execut..
 Common Stock 2,500 $14.57 $36,425
Purchase
MOULDER LEON O JR director, officer: Chief Execut..
 Common Stock 7,500 $15 $112,500
ZBIO insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Zenas BioPharma stock today?

    One share of Zenas BioPharma stock can currently be purchased for approximately $15.5.

  • When is Zenas BioPharma's next earnings date?

    Unfortunately, Zenas BioPharma's (ZBIO) next earnings date is currently unknown.

  • Does Zenas BioPharma pay dividends?

    No, Zenas BioPharma does not pay dividends.

  • How much money does Zenas BioPharma make?

    Zenas BioPharma has a market capitalization of 401.19M.

  • What is Zenas BioPharma's stock symbol?

    Zenas BioPharma, Inc. is traded on the NASDAQ under the ticker symbol "ZBIO".

  • What is Zenas BioPharma's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Zenas BioPharma?

    Shares of Zenas BioPharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Zenas BioPharma have?

    As Dec 2024, Zenas BioPharma employs 114 workers.

  • When Zenas BioPharma went public?

    Zenas BioPharma, Inc. is publicly traded company for just a year since IPO on 13 Sep 2024.

  • What is Zenas BioPharma's official website?

    The official website for Zenas BioPharma is zenasbio.com.

  • Where are Zenas BioPharma's headquarters?

    Zenas BioPharma is headquartered at North Building, Waltham, MA.

  • How can i contact Zenas BioPharma?

    Zenas BioPharma's mailing address is North Building, Waltham, MA and company can be reached via phone at (857) 271-2954.

Zenas BioPharma company profile:

Zenas BioPharma, Inc.

zenasbio.com
Exchange:

NASDAQ

Full time employees:

114

Industry:

Biotechnology

Sector:

Healthcare

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts.

(857) 271-2954
North Building
Waltham, MA 02451

CIK: 0001953926
ISIN: US98937L1052
: